Asterias’s stem cell therapy shows promise in study – Business Insider

Asterias's stem cell therapy shows promise in studyBusiness Insider(Reuters) - Asterias Biotherapeutics Inc said initial data from a small study showed that its lead stem cell therapy could improve mobility in patients paralyzed by a spinal cord injury. The therapy, AST OPC-1, is the first product derived from human ...and more
http://blog.zandcell.com/asteriass-stem-cell-therapy-shows-promise-in-study-business-insider/